Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial

A. S. Mansfield, A. Każarnowicz, N. Karaseva, A. Sánchez, R. De Boer, Z. Andric, M. Reck, S. Atagi, J. S. Lee, M. Garassino, S. V. Liu, L. Horn, X. Wen, C. Quach, W. Yu, F. Kabbinavar, S. Lam, S. Morris, R. Califano

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial'. Together they form a unique fingerprint.

Medicine & Life Sciences